Canopy Growth Corporation CGC · Stock Open Canopy Growth Corporation in new tab
Canopy Growth Corporation Analysis (CGC)
Is Canopy Growth Corporation a good investment? Canopy Growth Corporation (CGC) is currently trading at 1.00 USD.
Earnings Schedule: Canopy Growth Corporation is expected to release its next earnings report on Nov. 6, 2026. The market consensus estimate for Forward EPS is -0.12.
Investor FAQ
Does Canopy Growth Corporation pay a dividend?
No, it does not currently pay a dividend.
What asset class is Canopy Growth Corporation?
Canopy Growth Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 6, 2026. The company currently has a trailing EPS of -0.48.
Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 20, 2023 | 0.100000 |
Community Discussion